To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
for Chronic Obstructive Pulmonary Disease (COPD)
12 locations incl. Phoenix
Sponsor: Expedition Therapeutics, Inc
Sex: All·Age: 40 - 85
Code: NCT07684820·Phase 2·Recruiting·Listed Jul 6, 2026